O'FALLON, Mo., Oct. 12 // -- Synergetics USA, Inc. (NASDAQ:SURG) announced today that it has begun to ship Malis(R) Advantage(TM) units. The Malis(R) Advantage(TM) is the successor to one of the most successful neurosurgical electrosurgical cutting and coagulation devices in the marketplace... the Codman CMC-III. The CMC-III continues to be manufactured by Synergetics and sold through Codman worldwide.
"The Advantage(TM) units have been in regulatory approvals for some time. We have successfully completed electromagnetic compatibility and safety testing required to sell the Malis(R) Advantage(TM) in the United States and the European Union," said Gregg D. Scheller, President and Chief Executive Officer of Synergetics USA, Inc. "We await formal paperwork from our safety testing agency, but the testing has been successfully completed. Upon receipt of the paperwork, we will begin to ship the first Advantage(TM) units to both domestic and international customers against existing backorders."
"Our entire electrosurgical product launch has been awaiting this moment. I am excited to finally have this process completed. I know that our domestic and international sales networks are too. We can now begin in earnest to sell an equipment line that includes two generators, an irrigation module and a growing line of accessories and instruments."
Although the United States and European Union requirements have been successfully achieved, the registration process continues in other countries, including a significant one in Japan. The Company remains confident these processes will be completed in a timely manner.
About Synergetics USA, Inc.
Synergetics USA, Inc. resulted from the September 2005 combination of Valley Forge Scientific Corp. and Synergetics, Inc., bringing together their respective unique capabilities in bipolar electrosurgical generators and design, and manufacture of microsurgical hand instruments. Synergetics USA, Inc. designs, manufactures and markets medical devices for use primarily in ophthalmic surgery and neurosurgery and for other healthcare applications. Its products are designed and manufactured to support micro or minimally invasive surgical procedures. In addition to its surgical devices and equipment, it designs and manufactures disposable and non-disposable supplies and accessories for use with such devices and equipment. It also manufactures and sells bipolar electrosurgical generators and other generators, based on its DualWave(TM) technology, and complementary instrumentation and disposable products for use in neurosurgery, spine surgery, pain control and in dental applications. Synergetics sells its products primarily to hospitals, clinics and surgeons in approximately 70 countries.
SYNERGETICS USA, INC.
3845 Corporate Centre Drive
O'Fallon, Missouri 63368
Attn: Pamela G. Boone, Chief Financial Officer
Source: Synergetics USA, Inc.
CONTACT: Pamela G. Boone of Synergetics USA, Inc., Chief Financial Officer, +1-636-939-5100
Web site: www.synergeticsusa.com/